RPRX
Royalty Pharma Plc
NASDAQ: RPRX · HEALTHCARE · BIOTECHNOLOGY
$54.87
-0.76% today
Updated 2026-06-12
Market cap
$31.60B
P/E ratio
28.88
P/S ratio
12.95x
EPS (TTM)
$1.90
Dividend yield
1.62%
52W range
$34 – $57
Volume
3.6M
Royalty Pharma Plc (RPRX) Insider transactions
Net insider activity
Net selling (769,598 shares)
Buy transactions
34
Sell transactions
66
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | WEATHERMAN, ELIZABETH H | Director | Buy | 4,545 | — | — |
| 2026-06-05 | NORDEN, GREGORY | Director | Buy | 4,545 | — | — |
| 2026-06-05 | LOVE, TED W | Director | Buy | 4,545 | — | — |
| 2026-06-05 | HODGSON, DAVID C | Director | Buy | 4,545 | — | — |
| 2026-06-05 | HO, CAROLE | Director | Buy | 4,545 | — | — |
| 2026-06-05 | ENGELBERT, CATHERINE M. | Director | Buy | 4,545 | — | — |
| 2026-06-05 | CORIC, VLAD | Director | Buy | 4,545 | — | — |
| 2026-06-05 | BASSLER, BONNIE L | Director | Buy | 4,545 | — | — |
| 2026-05-26 | COYNE, TERRANCE P. | EVP & CFO | Sale | 64,399 | $53.98 | $3.48M |
| 2026-05-20 | URIST, MARSHALL | EVP, Research & Investments | Sale | 13,684 | $52.75 | $721837.84 |
| 2026-05-14 | URIST, MARSHALL | EVP, Research & Investments | Sale | 13,684 | $53.06 | $726137.35 |
| 2026-05-14 | NORDEN, GREGORY | Director | Sale | 3,045 | $53.00 | $161385.00 |
| 2026-05-06 | URIST, MARSHALL | EVP, Research & Investments | Buy | 18,197 | — | — |
| 2026-05-06 | LEGORRETA, PABLO G. | Director, CEO, Chairman of the Board | Buy | 143,821 | — | — |
| 2026-05-06 | HITE, CHRISTOPHER | EVP & Vice Chairman | Buy | 24,263 | — | — |
| 2026-05-06 | COYNE, TERRANCE P. | EVP & CFO | Buy | 24,263 | — | — |
| 2026-04-28 | COYNE, TERRANCE P. | EVP & CFO | Sale | 32,916 | $49.78 | $1.64M |
| 2026-04-28 | COYNE, TERRANCE P. | EVP & CFO | Sale | 1,875 | $49.78 | $93334.50 |
| 2026-04-01 | COYNE, TERRANCE P. | EVP & CFO | Sale | 32,916 | $48.33 | $1.59M |
| 2026-04-01 | COYNE, TERRANCE P. | EVP & CFO | Sale | 1,875 | $48.33 | $90622.13 |
| 2026-03-31 | BASSLER, BONNIE L | Director | Buy | 815 | $45.98 | $37471.25 |
| 2026-03-23 | COYNE, TERRANCE P. | EVP & CFO | Sale | 32,916 | $45.53 | $1.50M |
| 2026-03-23 | COYNE, TERRANCE P. | EVP & CFO | Sale | 1,875 | $45.53 | $85366.31 |
| 2026-03-02 | COYNE, TERRANCE P. | EVP & CFO | Sale | 22,487 | $46.67 | $1.05M |
| 2026-03-02 | COYNE, TERRANCE P. | EVP & CFO | Sale | 10,429 | $47.01 | $490314.22 |
| 2026-03-02 | COYNE, TERRANCE P. | EVP & CFO | Sale | 1,292 | $46.67 | $60303.71 |
| 2026-03-02 | COYNE, TERRANCE P. | EVP & CFO | Sale | 583 | $47.01 | $27409.34 |
| 2026-02-23 | COYNE, TERRANCE P. | EVP & CFO | Sale | 32,916 | $45.32 | $1.49M |
| 2026-02-23 | COYNE, TERRANCE P. | EVP & CFO | Sale | 1,875 | $45.32 | $84968.44 |
| 2026-02-11 | URIST, MARSHALL | EVP, Research & Investments | Buy | 19,970 | — | — |
| 2026-02-11 | LEGORRETA, PABLO G. | Director, CEO, Chairman of the Board | Buy | 157,828 | — | — |
| 2026-02-11 | HITE, CHRISTOPHER | EVP & Vice Chairman | Buy | 26,626 | — | — |
| 2026-02-11 | COYNE, TERRANCE P. | EVP & CFO | Buy | 26,626 | — | — |
| 2026-02-04 | COYNE, TERRANCE P. | EVP & CFO | Sale | 19,076 | $43.29 | $825853.45 |
| 2026-02-04 | COYNE, TERRANCE P. | EVP & CFO | Sale | 1,087 | $43.29 | $47059.27 |
| 2026-02-03 | COYNE, TERRANCE P. | EVP & CFO | Sale | 108,759 | $42.84 | $4.66M |
| 2026-02-03 | COYNE, TERRANCE P. | EVP & CFO | Sale | 6,195 | $42.84 | $265413.00 |
| 2026-02-02 | COYNE, TERRANCE P. | EVP & CFO | Sale | 102,581 | $42.08 | $4.32M |
| 2026-02-02 | COYNE, TERRANCE P. | EVP & CFO | Sale | 5,843 | $42.08 | $245896.23 |
| 2026-01-30 | URIST, MARSHALL | EVP, Research & Investments | Sale | 20,000 | $41.09 | $821810.00 |
| 2026-01-23 | URIST, MARSHALL | EVP, Research & Investments | Sale | 20,000 | $40.26 | $805110.00 |
| 2026-01-20 | COYNE, TERRANCE P. | EVP & CFO | Sale | 65,832 | $39.35 | $2.59M |
| 2026-01-20 | COYNE, TERRANCE P. | EVP & CFO | Sale | 3,750 | $39.35 | $147556.50 |
| 2026-01-16 | URIST, MARSHALL | EVP, Research & Investments | Sale | 20,000 | $39.52 | $790346.00 |
| 2026-01-09 | URIST, MARSHALL | EVP, Research & Investments | Sale | 20,000 | $40.78 | $815634.00 |
| 2026-01-02 | URIST, MARSHALL | EVP, Research & Investments | Sale | 20,000 | $38.48 | $769650.00 |
| 2026-01-02 | COYNE, TERRANCE P. | EVP & CFO | Sale | 65,832 | $38.42 | $2.53M |
| 2026-01-02 | COYNE, TERRANCE P. | EVP & CFO | Sale | 3,750 | $38.42 | $144058.88 |
| 2025-12-31 | BASSLER, BONNIE L | Director | Buy | 967 | $38.74 | $37463.32 |
| 2025-12-26 | URIST, MARSHALL | EVP, Research & Investments | Sale | 20,000 | $39.32 | $786380.00 |
| 2025-12-19 | URIST, MARSHALL | EVP, Research & Investments | Sale | 20,000 | $38.38 | $767582.00 |
| 2025-12-18 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 30,654 | $38.50 | $1.18M |
| 2025-12-17 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 79,346 | $38.57 | $3.06M |
| 2025-12-16 | URIST, MARSHALL | EVP, Research & Investments | Sale | 20,000 | $38.32 | $766420.00 |
| 2025-12-15 | COYNE, TERRANCE P. | EVP & CFO | Sale | 65,832 | $38.36 | $2.53M |
| 2025-12-15 | COYNE, TERRANCE P. | EVP & CFO | Sale | 3,750 | $38.36 | $143850.38 |
| 2025-12-05 | URIST, MARSHALL | EVP, Research & Investments | Sale | 23,334 | $39.15 | $913591.44 |
| 2025-12-05 | URIST, MARSHALL | EVP, Research & Investments | Sale | 18,242 | $39.15 | $714223.55 |
| 2025-12-03 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 110,000 | $39.77 | $4.38M |
| 2025-12-01 | URIST, MARSHALL | EVP, Research & Investments | Sale | 23,333 | $39.93 | $931633.02 |
| 2025-12-01 | URIST, MARSHALL | EVP, Research & Investments | Sale | 18,242 | $39.90 | $727855.80 |
| 2025-12-01 | COYNE, TERRANCE P. | EVP & CFO | Sale | 65,832 | $39.87 | $2.62M |
| 2025-12-01 | COYNE, TERRANCE P. | EVP & CFO | Sale | 3,750 | $39.87 | $149497.50 |
| 2025-11-24 | COYNE, TERRANCE P. | EVP & CFO | Sale | 55,146 | $38.67 | $2.13M |
| 2025-11-24 | COYNE, TERRANCE P. | EVP & CFO | Sale | 10,686 | $37.96 | $405644.83 |
| 2025-11-24 | COYNE, TERRANCE P. | EVP & CFO | Sale | 3,126 | $38.67 | $120882.11 |
| 2025-11-24 | COYNE, TERRANCE P. | EVP & CFO | Sale | 624 | $37.96 | $23686.73 |
| 2025-11-19 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 47,798 | $38.28 | $1.83M |
| 2025-11-19 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 47,401 | $38.28 | $1.81M |
| 2025-11-19 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 25,530 | $38.28 | $977260.32 |
| 2025-11-19 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 4,628 | $39.01 | $180527.64 |
| 2025-11-19 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 4,599 | $39.01 | $179393.65 |
| 2025-11-19 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 2,770 | $38.29 | $106051.67 |
| 2025-11-19 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 2,470 | $39.01 | $96346.55 |
| 2025-11-19 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 230 | $39.03 | $8977.61 |
| 2025-11-17 | COYNE, TERRANCE P. | EVP & CFO | Sale | 65,844 | $39.30 | $2.59M |
| 2025-11-17 | COYNE, TERRANCE P. | EVP & CFO | Sale | 3,750 | $39.30 | $147390.00 |
| 2025-11-07 | URIST, MARSHALL | EVP, Research & Investments | Sale | 16,000 | — | — |
| 2025-11-07 | URIST, MARSHALL | EVP, Research & Investments | Buy | 160,000 | — | — |
| 2025-11-05 | URIST, MARSHALL | EVP, Research & Investments | Buy | 4,626 | — | — |
| 2025-11-05 | LLOYD, GEORGE W. | EVP, Investments & CLO | Buy | 6,168 | — | — |
| 2025-11-05 | LEGORRETA, PABLO G. | Director, CEO, Chairman of the Board | Buy | 36,559 | — | — |
| 2025-11-05 | HITE, CHRISTOPHER | EVP & Vice Chairman | Buy | 6,168 | — | — |
| 2025-11-05 | COYNE, TERRANCE P. | EVP & CFO | Buy | 6,168 | — | — |
| 2025-09-30 | BASSLER, BONNIE L | Director | Buy | 1,047 | $35.79 | $37469.20 |
| 2025-08-11 | NORDEN, GREGORY | Director | Sale | 33,500 | $36.23 | $1.21M |
| 2025-08-08 | URIST, MARSHALL | EVP, Research & Investments | Sale | 3,000 | — | — |
| 2025-08-08 | NORDEN, GREGORY | Director | Sale | 14,466 | — | — |
| 2025-08-08 | NORDEN, GREGORY | Director | Buy | 144,660 | — | — |
| 2025-08-08 | LLOYD, GEORGE W. | EVP, Investments & CLO | Sale | 8,500 | — | — |
| 2025-08-08 | LEGORRETA, PABLO G. | Director, CEO, Chairman of the Board | Sale | 60,000 | — | — |
| 2025-08-08 | COYNE, TERRANCE P. | EVP & CFO | Sale | 1,000 | — | — |
| 2025-08-06 | URIST, MARSHALL | EVP, Research & Investments | Buy | 2,772 | — | — |
| 2025-08-06 | LLOYD, GEORGE W. | EVP, Investments & CLO | Buy | 3,696 | — | — |
| 2025-08-06 | LEGORRETA, PABLO G. | Director, CEO, Chairman of the Board | Buy | 21,901 | — | — |
| 2025-08-06 | HITE, CHRISTOPHER | EVP & Vice Chairman | Buy | 3,696 | — | — |
| 2025-08-06 | COYNE, TERRANCE P. | EVP & CFO | Buy | 3,696 | — | — |
| 2025-07-31 | WEATHERMAN, ELIZABETH H | Director | Buy | 5,806 | — | — |
| 2025-07-31 | WEATHERMAN, ELIZABETH H | Director | Buy | 2,752 | — | — |
| 2025-07-31 | HO, CAROLE | Director | Buy | 5,806 | — | — |
Frequently asked questions
Are RPRX insiders buying or selling?
Over the transactions on record, RPRX insiders have been net sellers, with about $64.55M in stock sold across 66 sales, against 3 open-market purchases.
Does insider selling at RPRX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which RPRX insiders are selling the most?
Recent selling is concentrated in a few names. COYNE, TERRANCE P. accounts for the largest share on record, with about $38.31M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.